Once-daily QVA149 provides the same efficacy as the free combination of its monocomponents indacaterol and glycopyrronium: The BEACON study
Ronald Dahl, Dalal Jadayel, Vijay Alagappan, Hungta Chen, Donald Banerji
European Respiratory Journal 2013 42: P3390; DOI: